United States - English - NLM (National Library of Medicine)

imprimisrx pa, inc. d/b/a imprimisrx - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w), leucovorin calcium (unii: rpr1r4c0p4) (leucovorin - unii:q573i9dvlp) - pyrimethamine 12.5 mg

United States - English - NLM (National Library of Medicine)

dr.reddys laboratories inc - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) - treatment of toxoplasmosis: pyrimethamine is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. use of pyrimethamine is contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency.

United States - English - NLM (National Library of Medicine)

alvogen inc. - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) - treatment of toxoplasmosis: pyrimethamine is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. use of pyrimethamine is contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency.

United States - English - NLM (National Library of Medicine)

fera pharmaceuticals, llc - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) - treatment of toxoplasmosis: pyrimethamine is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. use of pyrimethamine is contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency.

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals, inc. - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) - treatment of toxoplasmosis : pyrimethamine tablets are indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. use of pyrimethamine tablets are contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency.

United States - English - NLM (National Library of Medicine)

aurobindo pharma limited - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) - treatment of toxoplasmosis: pyrimethamine tablets are indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. use of pyrimethamine tablets are contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency.

United States - English - NLM (National Library of Medicine)

vyera pharmaceuticals llc - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) - pyrimethamine 25 mg - treatment of toxoplasmosis: daraprim is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. use of daraprim is contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency.

United States - English - NLM (National Library of Medicine)

oakrum pharma, llc - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) - treatment of toxoplasmosis: pyrimethamine is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. use of pyrimethamine is contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency.

Bangladesh - English - DGDA (Directorate General of Drug Administration)

super power pharmaceuticals ltd. - pyrimethamine + sulfaquinoxaline sodium - oral solution - 15 gm + 50 gm/100 ml

Bangladesh - English - DGDA (Directorate General of Drug Administration)

techno drugs ltd. - pyrimethamine + sulfaquinoxaline sodium - oral solution - 15 gm + 50 gm/100 ml